Magnitude of IFN-γ production in HIV-1-infected children is associated with virus suppression

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 2, 2002, Pages 255-261

  Reuben, James M ^a   Lee, Bang Ning ^a   Paul, Mary ^a   Kline, Mark W ^a   Cron, Stanley G ^a   Abramson, Stuart ^a   Lewis, Dorothy ^a   Kozinetz, Claudia A ^a   Shearer, William T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytokine production; Highly active antiretroviral therapy; Immune restoration; Pediatric HIV; Virus suppression

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; DIDANOSINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE;

EID: 0036676325     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.125979     Document Type: Article

References (22)

1. Immune repopulation after HAART in previously untreated HIV-1-infected children
2. Immunologic and virologic responses to HAART in severely immuno-compromised HIV-1-infected children
3. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
4. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
5. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, retonavir
6. Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy
7. Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy
8. Type 1 and Type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus
9. 1994 Revised classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age
10. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA
11. Increased levels of apoptosis of leukocyte subsets in cultured PBMCs compared to whole blood as shown by AnnexinV binding: Relevance to cytokine production
12. TNF alpha production by whole blood from HIV-1 infected patients
13. More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes
14. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: Evidence for impaired CTL effector function
15. The role of IL-10 in cross regulation of Th1 and Th2 responses
16. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection
17. Viral genetic heterogeneity in HIV-1-infected individuals is associated with increasing use of HAART and higher viremia
18. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
19. Early recovery of CD4+ T lymphocytes in children on highly antiretroviral therapy. Dutch study group for children with HIV infection
20. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with different disease progression: Reciprocal interferon-γ and interleukin-10 responses
21. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus
22. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children